U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.

Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.

Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...

The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has ...

Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...

The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...

Loomer, who seems to enjoy ready access to the president’s ear, on Thursday unveiled a tip line to help fire more Trump ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

Tidmarsh will temporarily guide CBER’s regulatory activities while the FDA searches for a permanent department lead.